Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

J J Body, I J Diel, M Lichinitzer, A Lazarev, M Pecherstorfer, R Bell, D Tripathy, B Bergstrom

Research output: Journal article (peer-reviewed) › Journal article

298 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry